Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Abiy B. Ambaye"'
Publikováno v:
Academic Pathology, Vol 4 (2017)
Many pathology departments are introducing subspecialty sign-out in surgical pathology. In 2014, the University of Vermont Medical Center transitioned from general sign-out to partial subspecialty sign-out to include gastrointestinal and breast/cervi
Externí odkaz:
https://doaj.org/article/a5c9088ac5a74fe2a804d2573741f546
Publikováno v:
Cancer Research. 81:PS5-11
Background: HER-2 testing informs prognosis and critically guides therapy in breast cancer. Current guidelines for immunohistochemistry (IHC) testing define 3+ as positive, 0 and 1+ as negative, and 2+ as equivocal with additional testing recommended
Autor:
Benjamin L. Witt, Wenhua Zhou, Abiy B. Ambaye, Andrew Bellizzi, Christine N. Booth, Kaitlin Sundling, Lananh Nguyen, Donna K Russell, Malcolm Schinstine, Paul N. Staats, Jean Thomsen, Megan Troxell, Rhona J. Souers, James Dvorak, Xiaoqi Lin, Daniel F. I. Kurtycz
Publikováno v:
Archives of pathologylaboratory medicine.
Context.— Most laboratories currently use patient tissues for validating immunohistochemical stains. Objective.— To explore advantages of using cell lines with known antigenicity as a validation method. Design.— Five American Type Culture Colle
Autor:
Thomas A. Summers, Patti A. Loykasek, Jeff Goldsmith, Dylan V. Miller, Kurt B. Schaberg, Yaping Wu, Dennis P. O'Malley, Jinru Shia, Abiy B. Ambaye, Robert A. Schwartz, Jingxin Qiu, Paul E. Swanson, Andrew M. Bellizzi, Megan L. Troxell, Thomas Haas, Regan Fulton, Patrick L. Fitzgibbons, Mohamed E. Salama
Publikováno v:
Archives of Pathology & Laboratory Medicine. 143:907-909
Publikováno v:
Archives of Pathology & Laboratory Medicine. 141:1523-1528
Context.—Breast reduction mammaplasty (RMP) for symptomatic macromastia or correction of asymmetry is performed in more than 100 000 patients per year in the United States. The reported incidence of significant pathologic findings (SPF), that is, c
Autor:
Eunhee S. Yi, Daniel T. Merrick, Lauren M. Moore, Hadi Yaziji, Richard W. Cartun, Lynette M. Sholl, Patricia Gaule, Allen M. Gown, Jason L. Hornick, John J. McGuire, Balazs Acs, Jingxin Qiu, Zhong J. Zhang, David L. Rimm, Mary Beth Beasley, Jill Walker, Wei-Lien Wang, Delphine Cougot, Abiy B. Ambaye, Sandra Martinez-Morilla, Mari Mino-Kenudson
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology
Programmed death 1 ligand 1 (PD-L1) Immunohistochemistry (IHC) is the key FDA-approved predictive marker to identify responders to anti-PD1 axis drugs. Multiple PD-L1 IHC assays with various antibodies and cut points have been used in clinical trials
Autor:
Aleksandra Ogrodnik, Ted A. James, Brianna Spencer, Gabriela Szalayova, Janice Y. Bunn, Jacqueline E. Wade, Abiy B. Ambaye, Mercedes Rincon
Publikováno v:
Breast Cancer Research and Treatment. 157:461-474
Chronic inflammation is known to facilitate cancer progression and metastasis. Less is known about the effect of acute inflammation within the tumor microenvironment, resulting from standard invasive procedures. Recent studies in mouse models have sh
Publikováno v:
Journal of Hematopathology. 9:53-58
Paired-box (PAX) genes constitute a family of genes involved in development. PAX5 is expressed in B lineage lymphomas. Recent studies report positive staining of polyclonal PAX8 in B cell proliferations due to N-terminus homology between PAX5 and PAX
Autor:
Yuan Gao, Abiy B. Ambaye, James G. Liu, Mari Mino-Kenudson, Michelle Yang, Juli-Anne Gardner, Ryan F. Coates, Joan M. Skelly, Richard Zubarick
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-7 (2018)
Biomarker Research
Biomarker Research
Background Diagnosing pancreatic ductal adenocarcinoma (PDAC) in the setting of metastasis with an unknown primary remains very challenging due to the lack of specific biomarkers. HNF-1B has been characterized as an important transcription factor for
Autor:
Richard Zubarik, Maura M. Barry, Abiy B. Ambaye, Jeannette Mitchell, Alexa M. Buskey, Valerie M. Cortright, Ryan F. Coates, Steven Ades, James G. Liu, Michelle Yang
Publikováno v:
Biomarker Research
Biomarker Research, Vol 6, Iss 1, Pp 1-7 (2018)
Biomarker Research, Vol 6, Iss 1, Pp 1-7 (2018)
Background Well-differentiated neuroendocrine tumors (NET) most frequently arise from the gastrointestinal tract (GI), pancreas, and lung. Patients often present as metastasis with an unknown primary, and the clinical management and outcome depend on